Cargando…

Restoring Inflammatory Mediator Balance after Sofosbuvir-Induced Viral Clearance in Patients with Chronic Hepatitis C

This study aimed at analyzing circulating levels of inflammatory and profibrogenic cytokines in patients with hepatitis C virus (HCV) chronic infection undergoing therapy with direct-acting antiviral agents (DAA) and correlating these immune biomarkers with liver disease status. We studied 88 Brazil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saraiva, Geórgia Nascimento, do Rosário, Natalia Fonseca, Medeiros, Thalia, Leite, Paulo Emílio Côrrea, Lacerda, Gilmar de Souza, de Andrade, Thaís Guaraná, de Azeredo, Elzinandes Leal, Ancuta, Petronela, Almeida, Jorge Reis, Xavier, Analúcia Rampazzo, Silva, Andrea Alice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994301/ https://www.ncbi.nlm.nih.gov/pubmed/29977152 http://dx.doi.org/10.1155/2018/8578051

Ejemplares similares

Innate Immune Response to Dengue Virus: Toll-like Receptors and Antiviral Response
por: Fernandes-Santos, Caroline, et al.
Publicado: (2022)

Pro-Inflammatory Profile of Children Exposed to Maternal Chikungunya Virus Infection during the Intrauterine Period: A One-Year Follow-Up Study
por: Faustino, Renan, et al.
Publicado: (2022)

ANÁLISE DA FREQUÊNCIA DE COINFECÇÕES POR SARS-COV-2 E DENV E AVALIAÇÃO DA GRAVIDADE DAS COINFECÇÕES EM RELAÇÃO ÀS MONOINFECÇÕES
por: Rodrigues, Joyce Carnevale, et al.
Publicado: (2022)

Cathepsin B and Plasma Kallikrein Are Reliable Biomarkers to Discriminate Clinically Significant Hepatic Fibrosis in Patients with Chronic Hepatitis-C Infection
por: Zanelatto, Alexia de Cassia Oliveira, et al.
Publicado: (2022)

Thrombocytopenia in Dengue: Interrelationship between Virus and the Imbalance between Coagulation and Fibrinolysis and Inflammatory Mediators
por: de Azeredo, Elzinandes Leal, et al.
Publicado: (2015)

The Role of Growth Factors in the Pathogenesis of Dengue: A Scoping Review
por: Fiestas Solórzano, Victor Edgar, et al.
Publicado: (2022)

Exploring Urinary Extracellular Vesicles and Immune Mediators as Biomarkers of Kidney Injury in COVID-19 Hospitalized Patients
por: Medeiros, Thalia, et al.
Publicado: (2022)

Analysis of a Routinely Used Commercial Anti-Chikungunya IgM ELISA Reveals Cross-Reactivities with Dengue in Brazil: A New Challenge for Differential Diagnosis?
por: Lima, Monique da Rocha Queiroz, et al.
Publicado: (2021)

Treatment with Sofosbuvir and Daclatasvir (with or without Ribavirin) Improves Patient Reported Outcomes in Hepatitis C
por: de Medeiros, Lucas Pereira Jorge, et al.
Publicado: (2018)

Sofosbuvir and daclatasvir
por: Hessel, Marleen H. M., et al.
Publicado: (2016)

Dengue Virus Induces NK Cell Activation through TRAIL Expression during Infection
por: Gandini, Mariana, et al.
Publicado: (2017)

Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Treated with Direct-Acting Antivirals
por: Leal, Cassia, et al.
Publicado: (2023)

Lead Toxicity Risks in Gunshot Victims
por: de Araújo, Gabriel Costa Serrão, et al.
Publicado: (2015)

Primary congenital bladder diverticula: Where does the ureter drain?
por: Macedo, Antonio, et al.
Publicado: (2015)

Changing the face of hepatitis C management – the design and development of sofosbuvir
por: Noell, Bennett C, et al.
Publicado: (2015)

The Metabolic Activation of Sofosbuvir Is Impaired in an Experimental Model of NAFLD
por: Gabbia, Daniela, et al.
Publicado: (2022)

Comparative Antiviral Efficacy of Generic Sofosbuvir versus Brand Name Sofosbuvir with Ribavirin for the Treatment of Hepatitis C
por: Tang, L., et al.
Publicado: (2018)

Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy
por: Janjua, Naveed Z., et al.
Publicado: (2019)

Efficacy of generic sofosbuvir with daclatasvir compared to sofosbuvir/ledipasvir in genotype 4 hepatitis C virus: A prospective comparison with historical control
por: Joharji, Hala, et al.
Publicado: (2022)

Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in Healthcare Workers and COVID-19 Patients
por: de-Oliveira-Pinto, Luzia Maria, et al.
Publicado: (2022)

Sofosbuvir: A Potential Treatment for Ebola
por: Reznik, Sandra E., et al.
Publicado: (2018)

Sofosbuvir/velpatasvir/voxilaprevir for hepatitis C
Publicado: (2019)

Potential Use of Sofosbuvir in the Prophylaxis for Rabies
por: Reznik, Sandra E., et al.
Publicado: (2020)

Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
por: McEwan, Phil, et al.
Publicado: (2017)

Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C
por: Ogawa, Eiichi, et al.
Publicado: (2020)

Sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir: novel treatment options for naïve and previously treated hepatitis C infection
por: Shin, Hyun Phil
Publicado: (2023)

Down-Regulation of Complement Receptors on the Surface of Host Monocyte Even as In Vitro Complement Pathway Blocking Interferes in Dengue Infection
por: Marinho, Cintia Ferreira, et al.
Publicado: (2014)

The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
por: Sacramento, Carolina Q., et al.
Publicado: (2017)

Real-world effectiveness and safety of sofosbuvir/velpatasvir and ledipasvir/sofosbuvir hepatitis C treatment in a single centre in Germany
por: Buggisch, Peter, et al.
Publicado: (2019)

Efficacy and safety of sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir for hepatitis C in Korea: a Phase 3b study
por: Heo, Jeong, et al.
Publicado: (2023)

Subsets of Cytokines and Chemokines from DENV-4-Infected Patients Could Regulate the Endothelial Integrity of Cultured Microvascular Endothelial Cells
por: Cipitelli, Marcio da Costa, et al.
Publicado: (2022)

A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection
por: Gobran, Samaa T., et al.
Publicado: (2021)

Increased Cytokeratin 19 Fragment Levels Are Positively Correlated with Adenosine Deaminase Activity in Malignant Pleural Effusions from Adenocarcinomas
por: Barillo, Jorge Luiz, et al.
Publicado: (2018)

Sofosbuvir Has Come Out of the Magic Box
por: Alavian, Seyed Moayed
Publicado: (2013)

A bibliometric analysis of the global research on sofosbuvir
por: Hernández-Vásquez, Akram, et al.
Publicado: (2017)

Use of sofosbuvir in chronic kidney disease: Is it necessary?
por: Lim, Tae Seop, et al.
Publicado: (2017)

Acute Interstitial Nephritis Associated with Sofosbuvir and Daclatasvir
por: Ashraf, Taha, et al.
Publicado: (2017)

Public funding for transformative drugs: the case of sofosbuvir
por: Barenie, Rachel E., et al.
Publicado: (2021)

Dengue Virus Activates Membrane TRAIL Relocalization and IFN-α Production by Human Plasmacytoid Dendritic Cells In Vitro and In Vivo
por: Gandini, Mariana, et al.
Publicado: (2013)

A simple way to treat penile concealing due to webbed penis
por: Macedo, Antonio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1eacobm72dhqrrbp5g0nhkpjmb